Production (Stage)
Predictmedix AI Inc.
PMED
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.40% | -49.87% | -52.14% | -67.49% | -46.04% |
| Depreciation & Amortization | -87.80% | -12.26% | -7.77% | -9.55% | -7.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.91% | -45.48% | -47.87% | -63.81% | -42.52% |
| Operating Income | -13.91% | 45.48% | 47.87% | 63.81% | 42.52% |
| Income Before Tax | -12.98% | -3.40% | 47.39% | 63.72% | 42.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.98% | -3.40% | 47.39% | 63.72% | 42.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.98% | -3.40% | 47.39% | 63.72% | 42.77% |
| EBIT | -13.91% | 45.48% | 47.87% | 63.81% | 42.52% |
| EBITDA | -15.18% | 78.69% | 44.11% | 60.43% | 42.79% |
| EPS Basic | 0.00% | -5.56% | 45.45% | 64.86% | 51.85% |
| Normalized Basic EPS | 0.00% | 45.45% | 50.00% | 65.22% | 52.94% |
| EPS Diluted | 0.00% | -5.56% | 45.45% | 64.86% | 51.85% |
| Normalized Diluted EPS | 0.00% | 45.45% | 50.00% | 65.22% | 52.94% |
| Average Basic Shares Outstanding | 16.12% | -0.06% | 1.63% | 7.15% | 12.95% |
| Average Diluted Shares Outstanding | 16.12% | -0.06% | 1.63% | 7.15% | 12.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |